Lestaurtinib

Lestaurtinib__FLT3, TrkA kinase inhibitor Grapiprant

Product Name Lestaurtinib
Description

FLT3, TrkA kinase inhibitor

Purity >98% (HPLC)
CAS No. 111358-88-4
Molecular Formula C26H21N3O4
Molecular Weight 439.5
Storage Temperature -20ºC
Shipping Temperature Shipped Ambient
Product Type Inhibitor
Solubility Soluble to 100 mM in DMSO and to 25 mM in ethanol
Source Synthetic
Appearance White powder
SMILES C@@67(N2C1=C5C(=C4C(=C1C3=C2C=CC=C3)CNC4=O)C8=C(N5email protected(O6)CC@7(O)CO)C=CC=C8)C
InChI InChI=1S/C26H21N3O4/c1-25-26(32,12-30)10-18(33-25)28-16-8-4-2-6-13(16)20-21-15(11-27-24(21)31)19-14-7-3-5-9-17(14)29(25)23(19)22(20)28/h2-9,18,30,32H,10-12H2,1H3,(H,27,31)/t18-,25+,26+/m1/s1
InChIKey UIARLYUEJFELEN-LROUJFHJSA-N
Safety Phrases Classification:
Not a hazardous substance or mixture.

Safety Phrases:
S22 – Do not breathe dust.
S24/25 – Avoid contact with skin and eyes.
S36/37/39 – Wear suitable protective clothing, gloves and eye/face protection.

Cite This Product Lestaurtinib (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-460)
Alternative Names KT5555, CEP-701, (9S,10S,12R)-2,3,9,10,11,12-Hexahydro-10-hydroxy-10-(hydroxymethyl)-9-methyl-9,12-epoxy-1H-diindolo1,2,3-fg:3',2',1'-klpyrrolo3,4-i1,6benzodiazocin-1-one
Research Areas Cancer, Apoptosis, Cancer Growth Inhibitors, Cell Signaling, Tyrosine Kinase Inhibitors
PubChem ID 126565
Scientific Background Lestaurtinib is potent JAK2, FLT3 and TrkA receptor tyrosine kinase inhibitor. Specifically, it prevents STAT5 phosphorylation. Lestaurtinib exhibits antiproliferative activity in vitro.
References 1. Weisel K.C., et al. (2007) Ann. NY Acad. Sci. 1106: 190–196.
2. Hexner E.O., et al. (2008) Blood. 111(12): 5663–5671.